For research teamsHelp me find a study
Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,057-4,068 of 4,306
Drug study icon
TerminatedNCT00857818

Study Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in people with Schizophrenia or Bipolarity type I Who Have Metabolic Syndrome

This study was terminated in Canada. It focuses on schizophrenia.

Multiple locations, including Calgary
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Canada
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
Recruitment unclearEUCTR 2017-000497-11

A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolarity type I Who are Early in Their Illness

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrug
Countries
Austria, Germany, Italy, ...
Sponsor
Alkermes Inc
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT03379597

Dietary Fiber and Probiotics Treatment for schizophrenia

This study is completed in China. It is testing dietary Fiber and Probiotics Treatment for schizophrenia.

In Changsha
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Central South University
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT07549581

SEP-380135 in Adults With Schizophrenia or Major Depressive Episode

This study is completed in the United States. It is testing SEP-380135 for depression.

In Los Alamitos
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Schizophrenia, ...DrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
View study
Drug study icon
CompletedNCT03818256

Safety study of safety, Efficacy, and Pharmacokinetics of Miricorilant in schizophrenia

This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.

Multiple locations, including Bentonville
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Corcept Therapeutics
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT01206517

Safety study of sublingual Asenapine in schizophrenia

This study is completed. It is testing sublingual Asenapine for schizophrenia.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
Sponsor
Organon and Co
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT04030143

A study of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT03854409

A study of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
View study
Other study type icon
CompletedNCT03386851

Abilify Maintena PMS in Schizophrenia Patients or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In Gwangju
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 19 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
WithdrawnNCT01981811

Medical Information Device #1 for schizophrenia

This study was withdrawn in the United States. It is testing Medical Information Device #1 for schizophrenia.

Multiple locations, including Cerritos
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
View study
Other study type icon
CompletedNCT01629355

Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Balsfjord
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaObservationalFrom 18 Years to 70 Years
Countries
Norway
Sponsor
University Hospital of North Norway
Condition
Bipolarity, Schizophrenia
View study
Other study type icon
CompletedNCT00666432

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hartford
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaObservationalOver 15 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Bipolarity, Schizophrenia
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.